Sai Life Sciences Limited (BOM: 544306)
India
· Delayed Price · Currency is INR
711.85
-15.20 (-2.09%)
At close: Jan 21, 2025
Sai Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 490.49 | 236.57 | 699.12 | 1,159 | 667.52 |
Short-Term Investments | 1,630 | 1,610 | 1,350 | 1,000 | 1,250 |
Cash & Short-Term Investments | 2,120 | 1,847 | 2,049 | 2,159 | 1,918 |
Cash Growth | -1.80% | -9.88% | -5.11% | 12.61% | - |
Accounts Receivable | 5,789 | 5,624 | 4,618 | 4,893 | 4,221 |
Other Receivables | 276.46 | 276.76 | 352.2 | 45.07 | 119.07 |
Receivables | 6,065 | 5,901 | 4,971 | 4,938 | 4,342 |
Inventory | 1,059 | 874.43 | 1,395 | 1,269 | 763.46 |
Prepaid Expenses | 250.85 | 212.12 | 150.76 | 173.28 | 71.95 |
Other Current Assets | 850.23 | 617.5 | 1,074 | 913.58 | 941.44 |
Total Current Assets | 10,346 | 9,451 | 9,640 | 9,454 | 8,036 |
Property, Plant & Equipment | 13,682 | 12,730 | 11,765 | 11,527 | 9,418 |
Long-Term Investments | 18.68 | 18.68 | 18.68 | 0.16 | 5.16 |
Other Intangible Assets | 120.8 | 137.73 | 114.33 | 80.5 | 55.75 |
Long-Term Deferred Tax Assets | 147.69 | 131.33 | 80.62 | 57.06 | - |
Other Long-Term Assets | 452.5 | 282.85 | 248.46 | 523.95 | 658.67 |
Total Assets | 24,768 | 22,751 | 21,866 | 21,642 | 18,174 |
Accounts Payable | 2,132 | 1,994 | 2,089 | 1,992 | 1,380 |
Accrued Expenses | 267.93 | 260.43 | 203.54 | 146.72 | 162.77 |
Short-Term Debt | 4,026 | 3,743 | 3,720 | 4,041 | 3,580 |
Current Portion of Long-Term Debt | 716.2 | 586.13 | 662.95 | 500.88 | 322.96 |
Current Portion of Leases | 550.37 | 417.76 | 373.49 | 245.61 | 106.4 |
Current Income Taxes Payable | - | - | 33.67 | 25.67 | 3.01 |
Other Current Liabilities | 770.43 | 397.62 | 505.76 | 194.45 | 433.05 |
Total Current Liabilities | 8,463 | 7,399 | 7,589 | 7,146 | 5,988 |
Long-Term Debt | 2,929 | 2,777 | 2,614 | 2,977 | 2,469 |
Long-Term Leases | 1,727 | 1,757 | 1,958 | 1,896 | 269.6 |
Long-Term Deferred Tax Liabilities | 967.24 | 862.66 | 625.34 | 625.99 | 613.77 |
Other Long-Term Liabilities | 62.45 | 60.93 | 76.11 | 72.91 | 67.94 |
Total Liabilities | 14,312 | 13,000 | 12,986 | 12,857 | 9,545 |
Common Stock | 183.99 | 176.63 | 176.23 | 175.56 | 174.3 |
Additional Paid-In Capital | 4,343 | 3,892 | 3,876 | 3,856 | 3,826 |
Retained Earnings | 5,812 | 5,534 | 4,696 | 4,641 | 4,561 |
Comprehensive Income & Other | 112.08 | 145.18 | 129.41 | 109.81 | 64.85 |
Total Common Equity | 10,451 | 9,748 | 8,877 | 8,782 | 8,626 |
Shareholders' Equity | 10,456 | 9,751 | 8,881 | 8,786 | 8,630 |
Total Liabilities & Equity | 24,768 | 22,751 | 21,866 | 21,642 | 18,174 |
Total Debt | 9,948 | 9,281 | 9,329 | 9,659 | 6,748 |
Net Cash (Debt) | -7,827 | -7,435 | -7,279 | -7,500 | -4,830 |
Net Cash Per Share | -42.12 | -40.65 | -39.91 | -41.30 | -28.02 |
Filing Date Shares Outstanding | 190.69 | 183.92 | 176.23 | 175.56 | 169.4 |
Total Common Shares Outstanding | 183.99 | 176.63 | 176.23 | 175.56 | 169.4 |
Working Capital | 1,883 | 2,052 | 2,051 | 2,308 | 2,049 |
Book Value Per Share | 56.80 | 55.19 | 50.37 | 50.02 | 50.92 |
Tangible Book Value | 10,330 | 9,610 | 8,763 | 8,701 | 8,570 |
Tangible Book Value Per Share | 56.15 | 54.41 | 49.72 | 49.56 | 50.59 |
Land | 188.63 | 188.63 | 174.98 | 164.86 | 166.32 |
Buildings | 3,086 | 3,055 | 2,614 | 2,134 | 1,786 |
Machinery | 9,565 | 8,872 | 7,118 | 6,724 | 6,419 |
Construction In Progress | 1,520 | 1,069 | 1,510 | 1,887 | 1,940 |
Leasehold Improvements | 173.39 | 169.27 | 174.29 | 168.75 | 88.9 |
Source: S&P Capital IQ. Standard template. Financial Sources.